Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 06, 2017

SELL
$72.11 - $85.47 $5.1 Million - $6.05 Million
-70,781 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
70,781
70,781 $5.01 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Salient Capital Advisors, LLC Portfolio

Follow Salient Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salient Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salient Capital Advisors, LLC with notifications on news.